Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao-Ke Tang

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Cardiology|July 10, 2022
PVT1 in cardiovascular disease: A promising therapeutic targetShang-Shu Tang, Heng Li, Chao-Ke Tang
International Journal of Cardiology|March 23, 2022
Targeting CA125 in cardiovascular diseaseGuang-Gui Zeng, Heng Li, Chao-Ke Tang
International Journal of Cardiology|May 26, 2022
HAND2-AS1: A novel therapeutic target for atherosclerosisGuang-Gui Zeng, Heng Li, Chao-Ke Tang
Frontiers in Pharmacology|September 6, 2023
Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and futureXiao-Er Tang, Ya-Qiong Cheng, Chao-Ke Tang
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 17, 2015
The protective functions of omentin in cardiovascular diseasesYu-Lin Tan, Xi-Long Zheng, Chao-Ke Tang
Advances in Clinical Chemistry|September 29, 2015
Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Atherosclerosis|February 7, 2012
Psychological stress, immune response, and atherosclerosisHong-feng Gu, Chao-ke Tang, Yong-zong Yang
Advances in Clinical Chemistry|August 2, 2015
Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|May 31, 2014
[Lipoprotein lipase and diabetic cardiomyopathy]Xiang-Yu Liu, Wei-Dong Yin, Chao-Ke Tang
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 2019
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic targetJia-Hui Gao, Xiao-Hua Yu, Chao-Ke Tang
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Cardiology|July 10, 2022
PVT1 in cardiovascular disease: A promising therapeutic targetShang-Shu Tang, Heng Li, Chao-Ke Tang
International Journal of Cardiology|March 23, 2022
Targeting CA125 in cardiovascular diseaseGuang-Gui Zeng, Heng Li, Chao-Ke Tang
International Journal of Cardiology|May 26, 2022
HAND2-AS1: A novel therapeutic target for atherosclerosisGuang-Gui Zeng, Heng Li, Chao-Ke Tang
Frontiers in Pharmacology|September 6, 2023
Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and futureXiao-Er Tang, Ya-Qiong Cheng, Chao-Ke Tang
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 17, 2015
The protective functions of omentin in cardiovascular diseasesYu-Lin Tan, Xi-Long Zheng, Chao-Ke Tang
Advances in Clinical Chemistry|September 29, 2015
Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Atherosclerosis|February 7, 2012
Psychological stress, immune response, and atherosclerosisHong-feng Gu, Chao-ke Tang, Yong-zong Yang
Advances in Clinical Chemistry|August 2, 2015
Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng, Chao-Ke Tang
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|May 31, 2014
[Lipoprotein lipase and diabetic cardiomyopathy]Xiang-Yu Liu, Wei-Dong Yin, Chao-Ke Tang
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 31, 2019
CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic targetJia-Hui Gao, Xiao-Hua Yu, Chao-Ke Tang
Pageof 14